NN Investment Partners Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.79M | Buy |
+10,948
| New | +$1.79M | 0.01% | 552 |
|
|
2021
Q4 | – | Sell |
-31,296
| Closed | -$5.91M | – | 785 |
|
|
2021
Q3 | $5.91M | Buy |
31,296
+5,470
| +21% | +$1.03M | 0.03% | 384 |
|
|
2021
Q2 | $4.38M | Buy |
25,826
+6,362
| +33% | +$1.08M | 0.02% | 429 |
|
|
2021
Q1 | $2.75M | Buy |
19,464
+2,851
| +17% | +$402K | 0.02% | 500 |
|
|
2020
Q4 | $2.16M | Buy |
16,613
+4,099
| +33% | +$533K | 0.01% | 507 |
|
|
2020
Q3 | $1.82M | Sell |
12,514
-164
| -1% | -$23.9K | 0.01% | 502 |
|
|
2020
Q2 | $1.88M | Buy |
+12,678
| New | +$1.88M | 0.01% | 508 |
|
|
2019
Q2 | – | Sell |
-13,266
| Closed | -$1.24M | – | 745 |
|
|
2019
Q1 | $1.24M | Buy |
+13,266
| New | +$1.24M | 0.01% | 567 |
|
|
2017
Q3 | – | Sell |
-5,858
| Closed | -$467K | – | 714 |
|
|
2017
Q2 | $467K | Buy |
+5,858
| New | +$467K | ﹤0.01% | 593 |
|
|
2016
Q4 | – | Sell |
-400
| Closed | -$27K | – | 900 |
|
|
2016
Q3 | $27K | Hold |
400
| – | – | ﹤0.01% | 848 |
|
|
2016
Q2 | $22K | Hold |
400
| – | – | ﹤0.01% | 855 |
|
|
2016
Q1 | $25K | Buy |
+400
| New | +$25K | ﹤0.01% | 847 |
|